Pramlintide
Metabolic & Weight ManagementSynthetic amylin analog for diabetes management, slows gastric emptying and reduces appetite.
Key Benefits
- ✓Improves glucose control
- ✓Reduces A1C
- ✓Promotes weight loss
- ✓Reduces insulin requirements
- ✓Decreases appetite
- ✓Slows gastric emptying
Dosing Information
Detailed Protocol
Administered via subcutaneous injection immediately before meals. Requires dose adjustments to insulin. Start with low dose and titrate up. Prescription required.
About Pramlintide
Pramlintide (Symlin) is a synthetic analog of human amylin, a hormone co-secreted with insulin. It slows gastric emptying, suppresses glucagon, and reduces appetite. FDA-approved as adjunct to insulin therapy in type 1 and type 2 diabetes.
Research Notes
FDA-approved in 2005 for diabetes. Clinical studies show improved glucose control and weight loss when added to insulin therapy. Requires careful insulin adjustment.
Potential Side Effects
- •Severe hypoglycemia risk
- •Nausea (very common)
- •Vomiting
- •Anorexia
- •Headache
- •Black box warning
Always consult with a healthcare professional before starting any peptide therapy.